Evidence map›Paper›PMID 24633895›Full record

ArticleJournal of pharmaceutical sciences2014

Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected.

Ryan F Donnelly, Karen Mooney, Maelíosa T C McCrudden, Eva M Vicente-Pérez, Luc Belaid, Patricia González-Vázquez, James C McElnay, A David Woolfson

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ryan F DonnellySchool of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, UK.
Karen Mooney
Maelíosa T C McCrudden
Eva M Vicente-Pérez
Luc Belaid
Patricia González-Vázquez
James C McElnay
A David Woolfson
Queen's University Belfast · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K020234/1Wellcome Trust 094085Wellcome Trust WT094085MA
6 · The paper itself

Abstract

We describe, for the first time, quantification of in-skin swelling and fluid uptake by hydrogel-forming microneedle (MN) arrays and skin barrier recovery in human volunteers. Such MN arrays, prepared from aqueous blends of hydrolyzed poly(methylvinylether/maleic anhydride) (15%, w/w) and the cross-linker poly(ethyleneglycol) 10,000 Da (7.5%, w/w), were inserted into the skin of human volunteers (n = 15) to depths of approximately 300 μm by gentle hand pressure. The MN arrays swelled in skin, taking up skin interstitial fluid, such that their mass had increased by approximately 30% after 6 h in skin. Importantly, however, skin barrier function recovered within 24 h after MN removal, regardless of how long the MN had been in skin or how much their volume had increased with swelling. Further research on closure of MN-induced micropores is required because transepidermal water loss measurements suggested micropore closure, whereas optical coherence tomography indicated that MN-induced micropores had not closed over, even 24 h after MN had been removed. There were no complaints of skin reactions, adverse events, or strong views against MN use by any of the volunteers. Only some minor erythema was noted after patch removal, although this always resolved within 48 h, and no adverse events were present on follow-up.

Indexed as

Administration, CutaneousAdultEquipment DesignFemaleHumansHydrogel, Polyethylene Glycol DimethacrylateMaleMicroinjectionsMiddle AgedNeedlesPolymersRecovery of FunctionSkinYoung AdultHydrogel, Polyethylene Glycol DimethacrylatePolymersdiffusionhydrogelmicroneedlemicroporeOCTpercutaneousskinskin barriertransdermal

Identifiers

PMID24633895
PMCPMC4119956
OpenAlexW1990001865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.